Echinacea 500 Mg Capsule
Natural health product licensed in Canada
- Licence holder
- CellChem Pharmaceuticals Inc.
- NPN or DIN-HM
- 80006824
- Status
- Active licence
- Licence date
- 25 July 2008
- Revision date
- 25 January 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Echinacée purpurea Source : Parties aériennes | 490 mg | Not calculated |
| Echinacée purpurea Source : Racine | 10 mg | Not calculated |
Non-medicinal ingredients
Phosphate de calcium, dibasique, Gélatine, Stéarate de magnésium, Eau, Microcrystalline cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
| Adolescentes | minimum: 14 years | Not specified | Not specified |
Uses authorised in Canada
Echinacea is used in Herbal Medicine to help fight off infections, especially of the upper respiratory tract. Supportive therapy in the treatment of upper respiratory tract infections (e.g. common colds). Help to relieve the symptoms and shorten the duration of upper respiratory tract infections.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use: if you have a progressive systemic disease such as tuberculosis, leukosis, collagenosis or multiple sclerosis; if you are taking immunosuppressants; if symptoms persist or worsen.
- Contre-indications
Do not use: if you are allergic to plants of the Asteraceao/Compositae/Daisy family
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80006824
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging